SLG
CL icon

Stanley-Laman Group’s Colgate-Palmolive CL Stock Holding History

Stanley-Laman Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,942
Closed -$267K – 270
2025
Q2 		$267K Buy
2,942
+413
+16% +$37.7K 0.04% 251
2025
Q1 		$237K Buy
2,529
+48
+2% +$4.3K 0.04% 258
2024
Q4 		$226K Sell
2,481
-6
-0.2% -$573 0.03% 264
2024
Q3 		$258K Hold
2,487
– – 0.04% 253
2024
Q2 		$241K Hold
2,487
– – 0.03% 254
2024
Q1 		$224K Buy
+2,487
New +$211K 0.03% 240
2022
Q3 		– Sell
-2,891
Closed -$232K – 243
2022
Q2 		$232K Sell
2,891
-976
-25% -$76.3K 0.04% 217
2022
Q1 		$293K Buy
+3,867
New +$306K 0.04% 241
2020
Q1 		– Sell
-6,121
Closed -$421K – 254
2019
Q4 		$421K Buy
+6,121
New +$417K 0.1% 207
2017
Q4 		– Sell
-2,839
Closed -$207K – 275
2017
Q3 		$207K Buy
+2,839
New +$205K 0.06% 196
2017
Q1 		– Sell
-8,230
Closed -$539K – 241
2016
Q4 		$539K Hold
8,230
– – 0.17% 171
2016
Q3 		$610K Hold
8,230
– – 0.25% 135
2016
Q2 		$602K Hold
8,230
– – 0.24% 148
2016
Q1 		$581K Sell
8,230
-13,334
-62% -$887K 0.11% 161
2015
Q4 		$1.44M Buy
21,564
+1,817
+9% +$121K 0.25% 110
2015
Q3 		$1.25M Buy
19,747
+482
+3% +$31.5K 0.26% 99
2015
Q2 		$1.26M Buy
19,265
+106
+0.6% +$7.19K 0.23% 111
2015
Q1 		$1.33M Buy
19,159
+1,458
+8% +$101K 0.24% 106
2014
Q4 		$1.23M Sell
17,701
-71
-0.4% -$4.79K 0.23% 113
2014
Q3 		$1.16M Buy
17,772
+622
+4% +$41K 0.23% 119
2014
Q2 		$1.17M Buy
17,150
+4,152
+32% +$278K 0.21% 119
2014
Q1 		$843K Buy
+12,998
New +$819K 0.15% 156

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stanley-Laman Group's CL Position: Q3 2025 in Review

Stanley-Laman Group sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 2,942 shares — an estimated $267K sold.

Stanley-Laman Group first reported a position in CL in Q1 2014 and held it in 22 quarters. The position peaked at $1.44M in Q4 2015. 1,845 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Stanley-Laman Group reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Stanley-Laman Group sold 2,942 Colgate-Palmolive shares in Q3 2025, an estimated $267K.
  • Stanley-Laman Group first reported a position in Colgate-Palmolive in Q1 2014 and held it in 22 quarters.
  • Stanley-Laman Group's Colgate-Palmolive position peaked at $1.44M in Q4 2015.
  • 1,845 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Stanley-Laman Group's 13F filing for Q3 2025, filed 22 Oct 2025.